BeOne Medicines (ONC) Operating Expenses (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Operating Expenses of $1.1 billion for Q1 2026, up 16.48% year-over-year from $941.2 million in Q1 2025, and down 6.35% quarter-over-quarter from $1.2 billion in Q4 2025.
BeOne Medicines (ONC) Operating Expenses (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Operating Expenses for 12 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 16.48% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $4.4 billion (up 14.2% YoY), while the FY2025 annual figure was $4.2 billion, up 11.71% from the prior year.
- Operating Expenses eased to $1.1 billion in Q1 2026 per ONC's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Operating Expenses topped out at $1.2 billion in Q4 2025 and bottomed at $562.2 million in Q4 2022.
- Historically, Operating Expenses has averaged $900.8 million across 5 years, with a median of $898.2 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 148.77% — and 2023, when it retreated 1.69%.
- BeOne Medicines' Operating Expenses stood at $562.2 million in 2022, then jumped by 62.27% to $912.4 million in 2023, then climbed by 14.72% to $1.0 billion in 2024, then grew by 11.85% to $1.2 billion in 2025, then slipped by 6.35% to $1.1 billion in 2026.
- Business Quant data shows ONC's Operating Expenses at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 367.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Bn |
| Mar 31, 2026 | 1.10 Bn |
| Dec 31, 2025 | 1.17 Bn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 1.06 Bn |
| Mar 31, 2025 | 941.18 Mn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 951.40 Mn |
| Jun 30, 2024 | 898.20 Mn |
| Mar 31, 2024 | 888.07 Mn |
| Dec 31, 2023 | 912.37 Mn |
| Sep 30, 2023 | 818.97 Mn |
| Jun 30, 2023 | 817.99 Mn |
| Mar 31, 2023 | 737.27 Mn |
| Dec 31, 2022 | 562.24 Mn |
| Sep 30, 2022 | 825.99 Mn |
| Jun 30, 2022 | 780.97 Mn |
| Mar 31, 2022 | 749.91 Mn |
| Dec 31, 2021 | -1.15 Bn |
| Sep 30, 2021 | 668.77 Mn |